PharVision Advisers »

Organogenesis Hldgs shares owned by PharVision Advisers

Quarter-by-quarter ownership of Organogenesis Hldgs (ORGO) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Organogenesis Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Organogenesis Hldgs held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Organogenesis Hldgs by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $155k 37k 4.22

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Organogenesis Hldgs

Soleus Capital Management
First Light Asset Management
Vanguard Group
BlackRock
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Geode Capital Management
State Street Corporation
Acadian Asset Management
Charles Schwab Investment Management
Renaissance Technologies
AQR Capital Management
Northern Trust
SG Americas Securities
D. E. Shaw & Co

View all funds holding Organogenesis Hldgs